Media Summary: For the launch of this year's Next Billion Dollar Startup list, we wanted to go back to the The FDA is changing how drugs get approved—and that could unleash a As language models like ChatGPT and Gemini have ushered in a

All Access Emerging Biotech Companies - Detailed Analysis & Overview

For the launch of this year's Next Billion Dollar Startup list, we wanted to go back to the The FDA is changing how drugs get approved—and that could unleash a As language models like ChatGPT and Gemini have ushered in a In this Lab to Impact session, Laurence Blumberg shares a candid CEO perspective on the realities of building and financing ... Drug developer Suma Krishnan was 51 when she had the idea for a topical gene therapy to treat a rare and terrible skin disorder, ... What happens when humans begin combining biology with technology, harnessing the power to recode life itself. What does the ...

Welcome to Biotecnika! Ready to transform your Doug Crawford, Ph.D., is the founder of MBC BioLabs and also a Managing General Partner of Mission BioCapital. Doug's goal is ... Emergence 2026 Day 1: Life Science Investor Day brings together 500+ investors at the Four Seasons, Sydney, for Australia's ...

Photo Gallery

All Access: Emerging Biotech Companies
Novartis Agrees $12 Billion Biotech Deal for Avidity
What It Takes To Build A $4.8 Billion Biotech Company | Forbes
How Surbhi Sarna Built A $275M Biotech Company From Nothing
4 Biotech Stocks on the Verge of Massive Breakthroughs
Why Nvidia, Google And Microsoft Are Betting Billions On Biotech’s AI Future
Lab to Impact: The Hard Reality of Building a Biotech Startup — A CEO’s Perspective
Benzinga All Access: Growing Biotechs
How This Biotech Entrepreneur Built A Multibillion-Dollar Company At Age 51
The 4 Ps of Biotech (And Why They're All Misaligned)
How to Launch a Biotech Startup in 2025 | Real Talk with Richard Bendis
BIOTECHNOLOGY in the Future: 2050 (Artificial Biology)
Sponsored
Sponsored
View Detailed Profile
Sponsored
Sponsored